# Bioequivalence Study of V0057 Versus a Reference Formulation After Single Administration in Healthy Male Subjects

> **NCT01861626** · PHASE1 · COMPLETED · sponsor: **Pierre Fabre Dermatology** · enrollment: 45 (actual)

## Conditions studied

- Healthy Volunteers

## Interventions

- **DRUG:** V0057 - A mg
- **DRUG:** Isotretinoin

## Key facts

- **NCT ID:** NCT01861626
- **Lead sponsor:** Pierre Fabre Dermatology
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 45 (ACTUAL)
- **Last updated:** 2013-06-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01861626

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01861626, "Bioequivalence Study of V0057 Versus a Reference Formulation After Single Administration in Healthy Male Subjects". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT01861626. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*